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ABSTRACT
The ubiquitin-proteasome system targets misfolded proteins for degradation. Since
the accumulation of such proteins is potentially harmful for the cell, their prompt
removal is important. E3 ubiquitin-protein ligases mediate substrate ubiquitination
by bringing together the substrate with an E2 ubiquitin-conjugating enzyme, which
transfers ubiquitin to the substrate. For misfolded proteins, substrate recognition is
generally delegated to molecular chaperones that subsequently interact with specific
E3 ligases. An important exception is San1, a yeast E3 ligase. San1 harbors extensive
regions of intrinsic disorder, which provide both conformational flexibility and sites
for direct recognition of misfolded targets of vastly different conformations. So far, no
mammalian ortholog of San1 is known, nor is it clear whether other E3 ligases utilize
disordered regions for substrate recognition.Here, we conduct a bioinformatics analysis
to examine >600 human and S. cerevisiae E3 ligases to identify enzymes that are similar
to San1 in terms of function and/or mechanism of substrate recognition. An initial
sequence-based database search was found to detect candidates primarily based on the
homology of their ordered regions, and did not capture the unique disorder patterns
that encode the functional mechanism of San1. However, by searching specifically for
key features of the San1 sequence, such as long regions of intrinsic disorder embedded
with short stretches predicted to be suitable for substrate interaction, we identified
several E3 ligases with these characteristics. Our initial analysis revealed that another
remarkable trait of San1 is shared with several candidate E3 ligases: long stretches of
complete lysine suppression,which in San1 limits auto-ubiquitination.We encode these
characteristic features into a San1 similarity-score, and present a set of proteins that are
plausible candidates as San1 counterparts in humans. In conclusion, our work indicates
that San1 is not a unique case, and that several other yeast and human E3 ligases have
sequence properties thatmay allow them to recognize substrates by a similarmechanism
as San1.
Subjects Bioinformatics, Cell Biology, Biochemistry
Keywords E3 ligase, Hrd1, San1, Intrinsic disorder, STUbL, Ubiquitin, Protein folding, Protein
degradation, Quality control
INTRODUCTION
A coordinated and efficient regulation of protein levels is of crucial importance to all
cells, and ubiquitin-mediated proteasomal degradation plays a central role in protein
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homeostasis. In addition to its role in controlling protein levels for regulatory purposes,
the proteasome also degrades misfolded proteins that may otherwise accumulate as toxic
protein aggregates.
Cellular proteins are targeted for proteasomal degradation by the attachment of multiple
moieties of the small regulatory protein ubiquitin, most often to lysine residues, but in some
cases also to serines, threonines or cysteines (Wang, Herr & Hansen, 2012). This process oc-
curs through the sequential action of a ubiquitin-activating enzyme (a so-called E1 enzyme),
a ubiquitin-conjugating enzyme (E2) and a ubiquitin-protein ligase (E3). First, an E1
enzyme gets activated with a ubiquitin moiety in an ATP-dependent process, and
subsequently passes on ubiquitin to an E2 enzyme. The E2 enzyme then interacts with an E3
ubiquitin-protein ligase. The most common class of E3 ligases contains a Really Interesting
New Gene (RING) domain, which acts to bind ubiquitin-conjugating E2 enzymes (Metzger
et al., 2014). RING E3 ligases thus bridge ubiquitin-charged E2s with substrates, which
then become ubiquitinated. Multiple rounds of this process ensure substrate poly-
ubiquitination, a requirement for degradation of most proteasomal substrates (for a
recent review of the ubiquitin-proteasome system see Kleiger & Mayor, 2014).
Although most components and the basic overall mechanisms of this system are well
understood, we still lack a comprehensive molecular understanding of how proteins are
recognized and marked for degradation. In some cases, E3 enzymes bind ancillary protein
factors that aid in the recognition of the substrate. The E3 enzyme CHIP, for example,
ubiquitinates misfolded proteins that are recognized and delivered to CHIP via Hsp70
chaperones (Arndt, Rogon & Hohfeld, 2007). In this case, recognition of partially folded or
misfolded substrates is offloaded to a chaperone, and the E3 enzyme then recognizes the
substrate-loaded Hsp70.
The use of protein co-factors to aid in substrate recognition is one solution to the problem
of how a fixed number of E3 enzymes can recognize the very large and conformationally
diverse set of substrates that the system must be able to deal with. Recently, however, an
alternative mechanism has been suggested for how the San1 E3 ligase from Saccharomyces
cerevisiae can recognize misfolded substrates. San1, a protein of 610 amino acids with a
RING domain spanning residues 165–280, appears to be largely devoid of well-defined
three-dimensional structure (Rosenbaum et al., 2011). Although the cytosolic Hsp70
chaperone Ssa1 and the ring-shaped Cdc48/p97 chaperone can assist in degradation of San1
substrates (Gallagher, Clowes Candadai & Gardner, 2014; Guerriero, Weiberth & Brodsky,
2013; Kriegenburg et al., 2014), a number of biochemical experiments strongly suggest that
the disordered parts of the San1 sequence provide direct binding sites for substrate proteins
targeted for degradation (Rosenbaum et al., 2011). In particular, throughout the disordered
regions of San1 there are several short hydrophobic stretches that function as substrate
binding sites (Rosenbaum et al., 2011). This distribution of substrate binding patches,
combined with the high flexibility of the disordered protein, allows San1 to interact with
multiple different misfolded proteins and bypasses the need for chaperones. Hence, the
intrinsic disorder present in San1 apparently underlies its ability to recognize misfolded
proteins. However, potentially due to the poor sequence conservation of disordered
proteins, it has not yet been possible to identify any San1 orthologs in higher eukaryotes.
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Intrinsic disorder in proteins is now recognized to be broadly distributed across all
kingdoms of life, and to play an important role in a large number of biological processes
(Dyson & Wright, 2005). The large flexibility of fully intrinsically disordered proteins, or
long stretches of intrinsic disorder in conjunction with well-folded domains, is believed
to provide a number of particular properties to proteins (Babu, Kriwacki & Pappu, 2012).
Importantly, the heterogeneous structures attained by these proteins allow them to bind
a broad range of target proteins, either through a process called folding-upon-binding in
which the disordered regions gain a specific structure upon binding to a target, or through
the formation of ‘‘fuzzy complexes’’ in which substantial disorder is retained (Cumberworth
et al., 2013).
The finding that San1 can recognize its protein substrates directly via its intrinsically
disordered regions prompted us to explore whether this mechanism might be employed
by other E3 enzymes. Using sequence conservation as a search criterion proved to be
insufficient in this respect, presumably due to the low levels of sequence conservation
that characterize intrinsically disordered protein regions. As an alternative, site-specific
disorder profiles have been shown to display substantial preservation through evolution
(Brown, Johnson & Daughdrill, 2010; Brown et al., 2011; Chen et al., 2006a; Chen et al.,
2006b;Daughdrill et al., 2007), and have recently been used as the basis for detecting similar
disorder functionalities across species (Mahani, Henriksson & Wright, 2013; Petrovich et al.,
2015). We employ such an approach here, by constructing a procedure that searches for
disorder properties similar to those of San1, combined with information about the unique
pattern of binding regions known from the San1 protein. A previous study of structural
disorder in the human ubiquitin-proteasome system found evidence for disorder in E1,
E2 and—to the greatest extent—E3 enzymes, and provided examples for how disordered
regions in E3 enzymes can function either as flexible linker regions or sometimes as sites for
interaction with folded domains in substrates (Bhowmick et al., 2013). Our work extends
this analysis by focusing on the extent to which E3 enzymes may use their intrinsic disorder
in direct substrate recognition. The method was applied on datasets of 563 human and
80 yeast E3 enzymes. We demonstrate that a number of human E3 enzymes, in addition
to displaying pervasive protein disorder, show two other hallmarks of the San1 sequence:
short stretches of higher order potentially involved in substrate binding and a remarkably
low content of lysine residues. Overall, our data indicate that San1 is not a unique case
among E3 ligases and that a number of these enzymes could display a substrate recognition
mode similar to San1.
RESULTS
Sequence-conservation based analyses reveal no obvious human
orthologs of San1
As yet, no human ortholog of yeast San1 is known. In a first attempt to identify such
a protein, we focused on the unusual RING domain of San1. Whereas a classical RING
domain has a consensus motif of Cys-X2-Cys-X9–39-Cys-X1−3-His-X2–3-Cys/Asn/His-
X2-Cys-X4–48-Cys-X2-Cys (where X represents any amino acid residue) (Budhidarmo,
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Nakatani & Day, 2012), the distance between the first Cys-X2-Cys sequence and the
following cysteine in the San1 RING domain is 88 residues (in S. cerevisiae), making it
unusually long. However, using MOTIF search (http://www.genome.jp/tools/motif/), an
algorithm designed to detect a specific sequence motif, we did not find obvious San1
candidates among the human proteins identified. Moreover, using the S. cerevisiae San1
RING domain in PSI-BLAST andDELTA-BLAST (Altschul et al., 1997) searches we did also
not detect any human E3 ligase comprising the same characteristic RING domain as San1.
To increase the sensitivity of the sequence-based search, we proceeded with anHMMSearch
protocol, where the San1 sequence was encoded into a hidden Markov model using the
jackhmmer program (both part of the HMMer software package; http://hmmer.org/).
This procedure detected a number of potential matches, but the hits were predominantly
defined by similarities in the ordered regions of San1—primarily the RING domain, and
the detected homologues did not generally display the disorder and binding patterns
characteristic of San1 (Fig. S1). In light of these results, we decided to search for human
E3 ligases that contain characteristic sequence features of San1 other than those associated
with the RING domain.
Initial San1-similarity analysis
Although San1 from S. cerevisiae is largely intrinsically disordered outside of the RING
domain, the flexible parts are predicted to contain short interspersed regions of higher
order that coincide with sequence conservation among orthologs in other yeast species
(Rosenbaum et al., 2011). Experimentally, it has been verified that these more ordered
regions confer substrate binding (Rosenbaum et al., 2011). The overall model that emerges
is therefore one where multiple binding sites (independently or in conjunction) can engage
the substrates, whereas the flexibility provided by the intrinsic disorder allows San1 to
adopt its structure to a wide variety of misfolded substrates (Rosenbaum & Gardner, 2011).
We therefore analyzed datasets of S. cerevisiae and human E3s to identify E3 enzymes
containing the same overall disorder/order signature as San1, in addition to a high overall
content of intrinsic disorder. Specifically, we employed the consensus disorder annotation
from the MobiDB database (Potenza et al., 2015) to identify regions of disorder in E3
enzymes (Fig. 1A, Table S1). For the San1 sequence, 78% was predicted to be disordered
(Fig. 1B, Table S1).
We used the ANCHOR predictor (Meszaros, Simon & Dosztanyi, 2009), which has also
been used in the characterization of San1 (Rosenbaum et al., 2011), to identify short regions
within the disordered parts of the E3 enzymes with a potential for molecular interactions.
Using only the amino acid sequence, ANCHOR predicts potential interaction sites present
within disordered regions. When employing a 0.5 threshold level, 53% of all residues in
San1 were predicted to be ANCHOR positive, with only four of the human E3 proteins
scoring higher (Table S1). In the case of San1, the regions of higher order that coincide with
sequence conservation among orthologs are generally 15–40 residues long (Rosenbaum et
al., 2011). To create an output to better detect a disorder/order pattern similar to the one in
San1, we therefore identified the total number of residues contained in ANCHOR positive
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Figure 1 San1 is highly disordered and contains a characteristic pattern of interspersed ANCHOR
positive regions for substrate interaction. (A) Disorder annotation of the S. cerevisiae San1 protein, as
provided by the MobiDB database (Potenza et al., 2015). Nine individual predictors were used by MobiDB
as the basis for a consensus annotation, which we used for all analyses in this paper. The darkness of the
shade of blue indicates how many of the nine predictors agree about the disorder annotation at a particu-
lar site. (B) Combined plot of the MobiDB consensus disorder annotation (blue) and the ANCHOR pre-
diction (red) for San1. The position of the RING domain is indicated. This compact view is used as the ba-
sis for the comparative analyses throughout the paper.
regions of length 15–40 in each protein of the datasets, and normalized it to the length of
the protein.
Plotting this ANCHOR score against the consensus disorder, and considering the
candidates with highest scores in both dimensions, we indeed found San1 at the top of the
yeast dataset, accompanied by a few other high-scoring candidates (e.g., Slx8; Figs. 2 and 3).
The disorder and ANCHOR profiles for several of the top candidates in the human dataset
(e.g., Rnf6, Rnf12, Pja1, Rn111; Figs. 2 and 3) showed clear similarities to the San1 profile,
with general high levels of disorder and the distinct ANCHOR propensity pattern. This
initial approach, based on a simple combination of disorder and anchor score, however,
had a few shortcomings. First of all, it relies on global high values of disorder, thereby
excluding proteins containing one or more ordered domains. Secondly, it fails to take into
account another remarkable feature of San1: long segments without a single occurrence of
lysine residues. Both these limitations are addressed below.
San1-like E3s show substantial lysine suppression
San1 has previously been reported to contain unusually few lysine residues (Fredrickson
et al., 2013) (Fig. 3 and Table S1). Since lysine is the most commonly used residue for
ubiquitin conjugation, and based on experimental evidence that the introduction of lysines
significantly destabilized the protein in cells, it was proposed that the low level of lysines
in San1 protects the protein from auto-ubiquitination and therefore from degradation
(Fredrickson et al., 2013). The few lysines present in San1 are found either within the RING
Boomsma et al. (2016), PeerJ, DOI 10.7717/peerj.1725 5/18
Figure 2 Characterization of the E3 dataset in terms of disorder and protein binding sites in disor-
dered regions. Plots of ANCHOR score versus fraction consensus disorder for all S. cerevisiae (A) and hu-
man (B) proteins in the datasets. Protein names are given for the top-scoring candidates, for which disor-
der and ANCHOR profiles are depicted in Fig. 3.
Figure 3 Identified San1-like E3 ligases show unusually low lysine content outside of the RING do-
main. Plots of the highest-scoring candidates obtained using a score consisting of the product of disorder
and anchor-stretch score. Each occurrence of a lysine residue is marked with a black dot.
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Figure 4 Low lysine content in San1 candidates is conserved broadly across species. The lysine distri-
butions of the candidates with strongest lysine suppression in Fig. 3 are compared to select orthologs from
representative species of evolutionary divergence, suggesting lysine suppression to be a strongly conserved
feature in these candidates. Note that the number below the alignment denotes the length of the alignment
(including gaps), rather than the query sequence length.
domain or in a short sequence stretch of relatively low disorder immediately adjacent
to this domain (Fig. 3, black dots), a feature which seems to be shared with several of
the highest scoring candidates (Fig. 3), in some cases to a remarkable extent (e.g., >600
consecutive residues were devoid of lysines in the case of RN111). The most significant
cases are highlighted in Fig. 4, demonstrating that the lysine suppression is strongly
conserved among orthologs in a range of different species. The lack of lysines is particularly
remarkable in light of the finding that disordered proteins are typically enriched in lysines
compared to folded proteins (Tompa, 2002). Taken together, these results suggest that the
San1-like E3 ligases identified here could employ the same strategy as San1 itself to avoid
auto-ubiquitination and degradation (but see also ‘Discussion’).
Definition of a San1 similarity score
Based on the considerations above, we developed a single score that quantifies whether a
protein displays general sequence properties that are similar to those of San1. The score
is based on disorder propensity, ANCHOR score and lysine suppression using a sliding
window approach. For each protein, every residue is assigned a score based on the three
quantities, calculated over a window centered at the residue in question (see Fig. 5): (a)
the percentage of residues with consensus disorder larger than 0.5, (b) the percentage
of residues within ANCHOR positive stretches, and (c) the longest lysine-free stretch of
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Figure 5 San1-like candidates can be detected using a feature-based similarity score. Top-scoring can-
didates retrieved when applying the sliding-window San1-similarity score (see Table S1). Three comple-
mentary quantities are calculated over a window of 150 residues: (1) the percentage of disorder, (2) the
percentage of residues within an ANCHOR positive stretch of length 15–40 and (3) the percentage of
residues occurring in the maximum lysine-free stretch within the window. The San1-similarity score is the
maximum value of the product of these numbers, with the corresponding window depicted as an orange
line under each plot. The window size is chosen to be of fixed size, and the score is therefore not defined
for the first and last 75 positions. Note that certain of the top-scoring candidates found using the San1
similarity score overlap with our initial, simpler approach that considered only disorder and ANCHOR
score over the entire sequence (see Fig. 3).
residues, normalized by the length of the window (chosen here as 150 residues). For each
position in the sequence, a product of these three quantities is calculated, and each protein
is represented with the maximum value (‘‘the San1 similarity score’’) observed among its
residues. Thus, proteins with a high San1 similarity score contain a particular region that
simultaneously has a high level of disorder, many potential sites for molecular interaction
and strong lysine suppression.
The top-scoring candidates based on this approach are presented in Fig. 5 (the full list
is available as Table S1). As expected, we find that San1 has one of the highest scores, with
only a few human candidates scoring higher. In general, we recover many of the candidates
found in the initial San1-similarity analysis presented above. As opposed to the initial
analysis, the window-based approach allows the identification of larger proteins with a
relatively low overall disorder, often reflecting the presence of one or more ordered regions
(domains). Two such examples include human Syvn1/Hrd1 and yeast Dma2 (Fig. 5). For
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a further discussion of the choice of parameters and how they affect the San1-similarity
score we refer to the ‘Methods’ section.
Analysis of potential functional orthologs of San1
Based on the bioinformatics investigation described above, we next analyzed specific
proteins with high San1 similarity in more detail founded on the current literature.
Specifically, among the top scoring hits in Fig. 5, we consider those candidates with known
links to protein quality control, i.e., the human E3s Syvn1/Hrd1 and Hecw1 and the yeast
E3s Doa10, Slx8, and Ufd4.
A well-characterized protein appearing in our analysis is human Syvn1/Hrd1, a
multispanning transmembrane protein of the ER. The low overall disorder displayed
by this protein is due to the transmembrane region ending at around residue 240, followed
by a disordered C-terminal cytosolic region, which is also low in lysine content (Fig. 5).
Curiously, the cytosolic tail of the budding yeast protein contains more lysines than in its
orthologs. Whether this difference reflects a basic difference in the respective functional
mechanisms is presently unknown.
Syvn1/Hrd1 is of particular interest in the current context, because it is known to
interact with misfolded proteins. Thus, Syvn1/Hrd1 is involved in targeting misfolded ER
and secretory proteins for proteasomal degradation in the cytosol through a process known
as ER-associated degradation (ERAD) (Christianson & Ye, 2014). In this process, misfolded
proteins are first recognized by ER lumenal chaperones and retrotranslocated across the
ER membrane. When emerging in the cytosol, substrate proteins are ubiquitinated by
ER-membrane localized E3 ligases, such as Syvn1/Hrd1, before they are finally degraded
by the 26S proteasome (Christianson & Ye, 2014). Along with the RING domain, the
predicted intrinsically disordered area in HRD1 faces the cytosol, and has so far not been
ascribed any particular function. Presumably, Syvn1/Hrd1 transiently engages the at least
partially extended ERAD substrates during ubiquitination, and the disordered region could
therefore play a role, similar to the situation for San1, in this function.
Intriguingly, another ERAD E3, Doa10, was one of the best scoring yeast E3s. Like
Syvn1/Hrd1, Doa10 is a multispanning transmembrane protein localized to the ER and
inner nuclear membrane where it targets a variety of misfolded proteins, e.g., squalene
monooxygenase, an enzyme involved in sterol homeostasis (Foresti et al., 2013), for
proteasomal degradation (Habeck et al., 2015 and references therein). As with Syvn1/Hrd1
the disordered region of Doa10 faces the cytosol, which fits well with its established role
in targeting also soluble nuclear and cytosolic proteins for degradation (Ravid, Kreft &
Hochstrasser, 2006).
Slx8 is a well-characterized SUMO-targeting ubiquitin ligase (STUbL). In the yeast
nucleus, Slx8 forms a heterodimer with Slx5 (Yang, Mullen & Brill, 2006) and targets a
number of sumoylated substrates for ubiquitin-dependent degradation (Uzunova et al.,
2007). At least part of the disordered region of Slx8 is required for heterodimer formation
with Slx5 (Westerbeck et al., 2014; Yang, Mullen & Brill, 2006), which contains the SUMO
interacting motifs that are required for substrate recognition. Similar to San1, the Slx5-Slx8
heterodimer has been shown to participate in protein quality control. Both SLX5 and
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SLX8 were identified as suppressors of a temperature sensitive mutant in the DNA binding
protein Mot1 (Wang, Jones & Prelich, 2006). At high temperatures, the mutant Mot1
protein is highly unstable, but stabilized in SLX5 and SLX8 null mutants (Wang, Jones &
Prelich, 2006). This is similar to how San1 was first connected to protein quality control
of the mutant proteins Sir4-9 and Cdc68-1 (Gardner, Nelson & Gottschling, 2005), and
suggests that the mutant Mot1 protein is still functional at the restrictive temperature,
but targeted for degradation. However, the degradation of Mot1 was also shown to
depend on the SUMO-ligases Siz1 and Siz2 (Wang, Jones & Prelich, 2006), revealing that
sumoylation of Mot1 was required for Slx5-Slx8 dependent degradation. Although in
sequence, they do not appear highly conserved, the mammalian STUbL Rnf4/Snurf is a
functional ortholog of budding yeast Slx5-Slx8 (Prudden et al., 2007; Sriramachandran &
Dohmen, 2014). However, as opposed to the situation with Slx5-Slx8 in yeast, Rnf4/Snurf
forms a homodimer (Plechanovova et al., 2011), which has primarily been connected with
the SUMO-dependent degradation of the Pml-Rarα oncoprotein (Tatham et al., 2008).
Of note, Rnf4/Snurf did not display a high San1-similarity score. However, another
less characterized human STUbL, Rn111 (Fig. 5), which is also involved in targeting
Pml-Rarα for SUMO-dependent degradation (Erker et al., 2013), did show similarity to
San1. In contrast to Rnf4/Snurf, Rn111 has also been shown to promote non-proteolytic,
K63-linked ubiquitination of SUMO-modified substrate proteins (Poulsen et al., 2013).
In addition to Syvn1/Hrd1, Doa10 and Slx8 described above, also Hecw1 and Ufd4 have
been connected with protein quality control. Specifically, Hecw1, also known as NEDL1,
was found to ubiquitinate amyotrophic lateral sclerosis (ALS)-linked SOD1 variants, but
not wild type SOD1 (Miyazaki et al., 2004). However, it is not clear that Hecw1 catalyzed
SOD1 ubiquitination leads to proteasomal degradation. Genetic experiments have also
linked the yeast E3 Ufd4 to protein quality control (Theodoraki et al., 2012), and showed
that Ufd4 as a proteasome-associated E3 (Xie & Varshavsky, 2002) targets an orphan
ER-membrane protein for degradation (Ravid & Hochstrasser, 2007).
DISCUSSION
The recognition and degradation ofmisfolded proteins by the ubiquitin-proteasome system
is of fundamental cellular importance. Only recently has it become clear that substrate
recognition does not always rely on molecular chaperones, but can also occur through a
direct binding mechanism involving intrinsic disorder, as employed by San1. We reasoned
that this mechanism might well be employed by other E3 ligases, featuring sequence
characteristics similar to San1 itself. While San1 is exclusively located in the nucleus
(Gardner, Nelson & Gottschling, 2005), the substrate recognition mechanism employed by
this protein could in principle also be employed by E3 ligases of the cytosol. Still, most of
the proteins we identify as being San1-like have been shown to localize to the nucleus (Her
& Chung, 2009; Liu et al., 2006; Xu et al., 2009). The underlying reason for this apparent
bias is presently unknown, although nuclear proteins in general appear to be enriched for
disorder as compared to, for example, cytosolic proteins (Ward et al., 2004). In addition,
the nucleus appears to be a particularly active organelle in regard to protein quality control
(Nielsen et al., 2014; Park et al., 2013).
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In the case of San1, it has been shown that one reason for its unusually low content
of lysine residues is to protect it from auto-ubiquitination and untimely proteasomal
degradation (Fredrickson et al., 2013). Many of the disordered San1-like E3s that we
identify here also display long stretches devoid of lysine residues. For instance, Rnf6 and
Rnf12 both contain a remarkably long stretch of around 500 residues devoid of lysines,
a feature conserved among their orthologs (Fig. 4). It is therefore possible that these
proteins employ the same strategy as San1 to avoid auto-ubiquitination and degradation.
Indeed, recent work shows a clear propensity for ubiquitinated lysines in proteasomal
substrates to occur in regions of intrinsic disorder, and moreover these lysines are often
located in close proximity to segments of >19 consecutive disordered residues (Guharoy
et al., 2016). However, since lysine residues can undergo numerous post-translational
modifications, including for instance sumoylation and acetylation, the low lysine content
need not necessarily be connected with ubiquitination and degradation. Indeed, for Dma2,
auto-ubiquitination followed by degradation was shown to occur despite the presence of a
region with low lysine content (Loring et al., 2008).
It is noteworthy that both Rn111 and Slx8 belong to the rather small family of STUbL-
type E3s. Since data suggest that several proteins are conjugated to SUMO in response to
heat shock (Tammsalu et al., 2014; Tatham et al., 2011), such STUbL E3s are likely to be
important for protein quality control. Indeed, like San1, Slx8 has been linked to protein
quality control (Wang, Jones & Prelich, 2006). However, since the SUMO interactingmotifs
that are found in STUbLs are generally located in intrinsically disordered regions (Vogt &
Hofmann, 2012), it cannot be ruled out that our approach is biased to detect STUbLs.
The concept that disorder can function to target protein misfolding in protein quality
control is not only known from the case of San1. Recently, a disordered region of
the cytosolic Bag6 protein, which functions to maintain misfolded aggregation-prone
ERAD substrates in solution en route to the proteasome (Wang et al., 2011), has been
demonstrated to bind and prevent aggregation of unfolded luciferase in vitro (Xu et al.,
2013). Moreover, it has recently become clear that Bag6 harbors multiple ‘‘hydrophobicity
recognizing’’ modules for binding of various substrates (Tanaka et al., 2016). Notably,
when applying our procedure to the human Bag6 sequence we find a San1-similarity score
of 0.51 (Fig. S2), similar to the highest scoring E3s in Fig. 5 (see Table S1). This suggests
that our approach could be useful also for identifying other components of the cellular
degradationmachinery. In the case of Bag6, we speculate that the low lysine content present
in the protein, although it is not itself an E3 ligase, protects the protein from ubiquitination
by E3 ligases, such as RNF126, with which Bag6 directly interacts (Rodrigo-Brenni, Gutierrez
& Hegde, 2014). Another recent example shows that a disordered C-terminal portion of
the Ube2w E2 enzyme recognizes only intrinsically disordered N-termini of proteins to
catalyze their N-terminal ubiquitination (Vittal et al., 2015). Indeed, we speculate that the
San1-like proteins identified here might fall into two different classes. One class, which
includes San1, Slx8 and Syvn1/Hrd1, appears to utilize its intrinsic disorder to identify a
broader range of misfolded substrates, whereas the other class might rather use disordered
regions to help recognize other substrates that perhaps themselves contain disordered
regions. The identification here of a number of San1-like human E3 ligases suggests that
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further examples could be added in the near future, opening up formore detailed functional
and biophysical studies of the mechanisms by which intrinsic disorder in E3 enzymes is
used to regulate protein homeostasis.
METHODS
HMM sequence-based search procedure
The hidden Markov model based sequence searches were conducted using the HMMER
software package (http://hmmer.org/) by constructing a model using the jackhmmer tool,
and subsequently using the hmmsearch program to search through the entire Uniprot
databases of Saccharomyces cerevisiae and human, respectively. Default values were used
for these programs. The top-10 matches for human and top-5 hits for yeast are included
as Fig. S1.
Datasets
For the remaining analyses, we searched directly within a set of 80 yeast E3 ligases (Li et al.,
2008) and a set of 563 human E3 ligases recently published by Tompa and coworkers
(Bhowmick et al., 2013). This set was constructed as a merge of an extract from the KEGG
BRITE database (Kanehisa & Goto, 2000) and well-characterized E3 ligases from a previ-
ously published dataset (Li et al., 2008), filtered for uncertain annotations, identical gene
names, and internal sequence homology (>85%), leading to an unbiased, representative set
of the currently known E3 proteins. It should be noted, however, that additional human E3
ligases probably exist (Bhowmick et al., 2013; Li et al., 2008), and more than 600 RING-type
E3 ligases are likely expressed in human cells (Deshaies & Joazeiro, 2009).
All results obtained in the analysis for this paper are made available as an annotation
of this original data set, presented as an Excel file in Table S1. This dataset contains all
position-specific prediction results, it provides the resulting San1 similarity score, and
allows for easy sorting of candidates based on the criteria outlined in the paper. The
spreadsheet also permits reanalyses of the data with different parameter values (e.g., the
lengths of the sliding window and the ANCHOR stretch).
Prediction of protein binding regions
We used the ANCHOR (Meszaros, Simon & Dosztanyi, 2009) program to assign position-
specific scores for protein binding within disordered regions. For the purpose of the San1
similarity score, we considered stretches of between 15 and 40 residues (see below) for
which the ANCHOR scores are all higher than 0.5. The total number of residues occurring
within such regions was normalized by the length of the window to give an ANCHOR
stretch score. No requirements were imposed on the disorder status of such regions.
Choice of parameters
The size of the sliding window and the boundaries defining an ANCHOR stretch (15–40),
are free parameters that we chose based on the observed features of San1. The window size
for lysine content was set to 150, which is compatible with the particular stretch found
in San1. Choosing larger values penalizes smaller proteins (candidates that are smaller
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than the window size will be assigned a score of zero), and choosing smaller values makes
the score less sensitive to long lysine-free stretches. The 15 and 40 residue ANCHOR
stretch boundaries were based directly on the lengths observed in San1 (Rosenbaum et
al., 2011). We probed the sensitivity of our approach to these choices by considering the
top candidates with varying values for both of these parameters and found the presented
results to be quite robust, as long as the chosen values were not directly at odds with the
characteristics observed for San1. For instance, when changing the ANCHOR stretch length
to 5–35, we find that 17 out of 20 of the Top 20 candidates in Table S1 are preserved.
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